[DOI] [PMC free article] [PubMed] [Google Scholar] 93.Sarzi-Puttini P., Giorgi V., Marotto D., Atzeni F
When to Use Compounded GLP-1s and How Provider Oversight Ensures Safety Compounded GLP-1 optionssemaglutide, tirzepatide, and microdose formulationsfrom licensed 503A pharmacies offer flexibility for patients with ulcerative colitis who require careful dose titration or have specific tolerability needs
An important note about that vertical axis
SURMOUNT-4 showed 89.5% of patients maintained at least 80% of their weight loss with continued treatment
After we added specific nutrients to my IV protocol, the symptoms became manageable enough that I could continue treatment without dose reductions." These anecdotal reports align with quality of life measurements in research studies
In addition, we have a library of information you can refer to if you ever have any questions